Statements (54)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Oncology
|
gptkbp:affects |
pleura
|
gptkbp:associated_with |
gptkb:Oncology
fibrosis pleural effusion |
gptkbp:caused_by |
asbestos exposure
|
gptkbp:clinical_trial |
ongoing
completed |
gptkbp:death |
low
|
gptkbp:diagnosis |
biopsy
poor imaging tests typically 60s to 70s |
gptkbp:financial_support |
gptkb:financial_assistance
gptkb:educational_resources counseling services palliative care support groups |
gptkbp:genetic_studies |
CDKN2 A deletion
BAP1 mutation NF2 mutation |
gptkbp:geographic_distribution |
higher in developed countries
higher in industrial areas |
https://www.w3.org/2000/01/rdf-schema#label |
pleural mesothelioma
|
gptkbp:legal_issue |
compensation claims
asbestos litigation |
gptkbp:number_of_stages |
stage I
stage IV stage II stage III |
gptkbp:occurs_in |
rare
|
gptkbp:public_awareness |
gptkb:Mesothelioma_Awareness_Day
Asbestos Awareness Month |
gptkbp:research_focus |
biomarkers
early detection treatment options |
gptkbp:risk_factor |
age
smoking gender |
gptkbp:symptoms |
chest pain
persistent cough shortness of breath |
gptkbp:treatment |
gptkb:surgery
variable radiation therapy chemotherapy depends on stage depends on patient health depends on tumor location depends on treatment type |
gptkbp:type |
malignant
primary |
gptkbp:bfsParent |
gptkb:malignant_mesothelioma
|
gptkbp:bfsLayer |
7
|